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Tremendous advances have occurred in our understanding of the pathogenesis of hand osteoarthritis
(OA) and these are beginning to be applied to trials targeted at modiﬁcation of the disease course. The
purpose of this expert opinion, consensus driven exercise is to provide detail on how one might use and
apply hand imaging assessments in disease modifying clinical trials. It includes information on acqui-
sition methods/techniques (including guidance on positioning for radiography, sequence/protocol rec-
ommendations/hardware for MRI); commonly encountered problems (including positioning, hardware
and coil failures, sequences artifacts); quality assurance/control procedures; measurement methods;
measurement performance (reliability, responsiveness, validity); recommendations for trials; and
research recommendations.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Substantial advances have occurred in our understanding of the
pathogenesis of hand osteoarthritis (OA) and these are beginning to
be applied to trials targeting modiﬁcation of the disease course1.: D.J. Hunter, Rheumatology
e of Bone and Joint Research,
Australia. Tel.: 61-2-9463-
Hunter).
ternational. Published by Elsevier LCurrent regulatory requirements for disease modiﬁcation require
that alongside the assessment of structural effects that symptom
improvement be demonstrated2. The previous guidelines for OA
clinical trials published in 19963 included recommendations for
imaging with a predominant focus on radiography (consistent with
the era); some details are provided in the appendices on methods
of acquiring radiographs and use of MRI. A more recent iteration
focused on hand OA recommended conventional radiographs to
image hand OA both for selection of patients and severity assess-
ment and also for monitoring progression in structure modifyingtd. All rights reserved.
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detail on the different imaging methods available, the pitfalls
inherent nor performance metrics of different imaging markers. Of
note, an updated guideline on the conduct of clinical trials in per-
sons with hand OA is included in this issue for OARSI clinical trial
guidance however it does not contain comprehensive detail on
imaging (Maheu et al.).
The purpose of this expert opinion, consensus driven exercise is
to provide detail to anyone performing or planning clinical trials,
imaging scientists and their respective teams on howonemight use
and apply this knowledge in disease modifying clinical trials uti-
lizing hand imaging assessments. It includes information on
acquisition methods/techniques (including guidance on posi-
tioning for radiography, sequence/protocol recommendations/
hardware for MRI); commonly encountered problems (including
positioning, hardware and coil failures, sequences artifacts); quality
assurance/control procedures; measurement methods; measure-
ment performance (reliability, responsiveness, validity); recom-
mendations for trials; and research recommendations.
Method
This review began with a search of Pubmed using terms of OA,
hand, and imaging. We also conducted general searches for man-
uscripts covering general randomized control trial (RCT) methods,
covering each of the sub-topics below; from this literature we
identiﬁed designs and methods, as well as other manuscripts of
high relevance. It should be noted that the vast majority of this
manuscript is based upon expert opinion of the diverse multidis-
ciplinary group involved in this exercise. Authors of this review
included multiple experts familiar with different approaches for
imaging of the hand joint, including radiologists, rheumatologists,
and engineers. This expert opinion was generated via a series of
teleconference and email exchanges followed by generation of a
series of recommendations. This correspondence allowed the
working group to identify additional topics and manuscripts for
inclusion and to develop and reach concurrence on a set of rec-
ommended principles for inclusion of hand imaging methods in OA
implementation trials. Given the potential for divergent perspec-
tives for the trial recommendations and research recommendations
a survey was conducted of these members to determine the
strength of recommendation for each point raised. Final recom-
mendations (Tables I and II) were obtained by averaging the re-
sponses to a survey among the 14 authors for the strength of
recommendation from 0 to 100. At the commencement of this
exercise all members of the working group were asked about
conﬂicts of interest and the results from those who were conﬂicted
were not included in the survey results. The focus of the content is
on radiography and MRI as the preferred imaging techniques with
some content on ultrasound when appropriate.
Acquisition methods and techniques
Radiography
Typical hand radiographs can be acquired with multiple
views5,6. The hand is usually evaluated with postero-anterior (PA)
and oblique views, occasionally with more detailed magniﬁed
views of the joint of interest7. For symptom-modifying trials, where
a radiograph is obtained for diagnostic purposes, a single PA
radiograph of both hands imaged side-by-side on the same cassette
is acceptable. For structure-modifying trials, however, a PA radio-
graph of each hand should be obtained on a separate cassette, with
the palm of the hand on the ﬁlm, the ﬁngers extended and
adducted, and the entire forearm resting on the X-ray table. Beam-centering and angulation (i.e., centered on the third meta-
carpophalangeal joint (MCP-3), perpendicular to the ﬁlm-screen or
receptor), focus-to-ﬁlm distance and exposure should be stan-
dardized across all participating imaging facilities.
Measures should be taken to ensure that the right and left hands
are accurately labeled. This is important because if a right hand at
baseline is compared to a left hand at follow-up that was errone-
ously labeled right, differences in the degree and distribution of
abnormalities can be misinterpreted as disease progression or
regression. Image labeling can be unreliable if radiopaque markers
are placed on the ﬁlm-screen manually. Anatomical asymmetries,
when noticed, can help identify labeling errors, but these are often
subtle, and many cases go unrecognized. Most clinical trials of
rheumatoid arthritis (RA) have overcome this error by utilizing
positioning frames with permanently embedded left-right markers
designed in such a way as to make it impossible to image a hand
with the wrong marker. As with knee radiography, changes in the
position of the hand can change JSW values8,9 and are likely to
affect measurements of osteophytes. The use of a hand positioner is
therefore recommended so that consistency is maintained both
cross-sectionally and longitudinally.
There are no published reports that quantify the effect of
radiographic technique (mA and kVp) on measurement error;
however these factors are unlikely to alter measurements of JSWor
osteophytes unless the quality is signiﬁcantly compromised. Hue-
tink et al.9 reported no systematic change in JSWas a function of the
ﬁlm-to-focus distance (FFD) for FFD covering 110e120 cm. Indeed
as long as the hand is placed directly on top of the detector and the
FFD is consistent at all time points for all patients, themagniﬁcation
factor will change negligibly as a function of FFD. Current posi-
tioners usually come with a calibration marker built in.
While no studies have speciﬁcally examined the effect on de-
tector pixel spacing on measurement accuracy or precision, studies
have shown comparable reproducibility of Genant-modiﬁed Sharp
scoring using screen-ﬁlm radiographs digitized at a pixel spacing of
0.1 mmwith that using the original ﬁlm-screen radiographs10, and
several studies have quantiﬁed reproducibility and average JSW
change from which it may be possible to draw conclusions about
requirements for spatial resolution. In a study of RA subjects Neu-
mann et al.11 reported a long term repositioning reducibility of
0.10 mm for screen-ﬁlm radiographs digitized at a pixel spacing of
0.1 mm. Finckh et al.12 reported an average JSW change of 0.16 mm
in RA subjects with a 4 year median follow-up time. In a phantom
study Huetink et al.9 reported a smallest detectable distance of
0.028 mm for JSW measured using a “standard digital X-ray im-
aging system”. Angwin et al.8 reported a value of 0.11 mm to
represent a threshold for “an actual physical change in joint space
width”. Together these studies suggest that clinical trials which use
radiographic JSW as an endpoint should use a detector with the
smallest pixel spacing possible and that the same imaging protocol
should be used for all time points.
MRI
Key factors in determining which MRI protocol to use to eval-
uate OA of the hand include themeasurement method to be used to
analyze the images, patient tolerance with respect to examination
time, speciﬁc needs or preferences of the readers, the degree of
heterogeneity of technology and experience among imaging cen-
ters participating in the study, whether the study design is cross-
sectional or longitudinal, and of course, any regulatory re-
quirements and budgetary constraints.
To support scoring with OMERACT Hand Osteoarthritis Mag-
netic Resonance Scoring System (HOAMRIS), MRI images must
cover at least the distal interphalangeal (DIP) and proximal
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possible, given the small size of these joints13,14. To optimize
scoring the sequences must be obtained in at least two planes or
with a three-dimensional technique with small isometric voxels in
one plane, 1 mm slice thickness and subsequent reconstruction15.
Accordingly, 1.5T or 3T scanners are recommended. Coverage of the
PIP and DIP joints can be accomplished with most commercial
surface coils, which are widely available and therefore applicable to
multicenter clinical trials. If additional coverage is needed, for
example to include the ﬁrst carpometacarpal (CMC-1) (see also
Research Recommendations), two separate scans with a surface coil
or a single large ﬁeld of view scanwith a knee coil will be necessary.
Multicenter imaging of the hand and wrist with larger coils has
been successfully performed in multicenter clinical trials of
RA16e18. Using a knee coil necessitates imaging the patient prone
with the arm extended over the head, which may be problematic
for patients with shoulder problems. If multicenter availability of
imaging technology is not a constraint, as in single-center studies,
specialized MRI systems, coils and set ups can be used. The focus in
this review, however, is themore constrained setting of multicenter
studies in which images acquired from diverse facilities must ulti-
mately be pooled for analysis. A key objective in this context is
minimizing technical differences among images from the different
centers, particularly spatial resolution and image contrast.
If longitudinal analyses are to be done, reproducible positioning
of the ﬁnger joints is critical, as even slight variations in their ori-
entations relative to each other will result in variable sectioning of
each bone and joint from scan to scan, regardless of how meticu-
lously the slices are prescribed. Reproducible positioning can be
facilitated by the use of specially designed acrylic frames that ﬁx
the orientation of ﬁnger joints, as has been the standard in clinical
trials of RA for years19.
Because of the anatomy of the ﬁnger joints, sagittal images are
most useful for evaluating articular cartilage. However, as in the
knee, coronal images may be adequate as well, and require less
than half the imaging time to achieve full coverage of the hand.
Axial images are not very useful for evaluating cartilage in the
ﬁngers, but are excellent for monitoring synovitis and tendons, as
well as associated ligamentous changes. Axial images, however, like
sagittal images, require longer scan times to cover the necessary
anatomy in the hand. Sagittal images are also important in the DIPFig. 1. Visualization of thumb base OA. A. T1-weighted spin echo MRI shows ulnar-sided ost
In addition there is subchondral sclerosis ideally visualized on T1-weighted images (arrow
concomitant synovitis surrounding the metacarpal osteophyte (black arrow) and subchondand PIP joints for evaluating dorsal-palmar osteophytes, which are
often prominent in hand OA. Bone erosions, subarticular cysts and
bone marrow lesions are all well visualized on coronal and sagittal
images (Figs. 1 and 2). Thus, MRI protocols including all three
orthogonal planes are ideal. However, because of imaging time
constraints, one may be practically limited to only one or two
planes (we would recommend sagittal and coronal). For example,
almost all randomized controlled clinical trials of RA usingMRI that
have been reported to date have been able to include only a single
plane of section (coronal). Despite this, most of these studies were
highly discriminative of progression of joint damage over short
follow-up intervals and with relatively small numbers of subjects
per arm. While it is difﬁcult to broadly generalize about resolution
given tradeoffs with imaging time, joint/s studied and SNR we
would make the following suggestions for sequence criteria for
high resolution and clinical studies. For clinical studies would
suggest minimal slice thickness: 1 mm for the 3D (SPGR, FLASH);
1.5 mm for proton density- and T1-weighted, 3 mm for the STIR;
Gap: no gap is preferable; and Field of view (FOV): 140 mm for the
hand, and 180 mm if wrist is included in coronal plane (120 mm in
axial plane). For high resolution studies would suggest: Minimal
slice thickness: 1 mm; Gap: no gap is preferable; and FOV: 40 or
45 mm.
With respect to pulse sequences, T1-weighted 3D gradient echo
images with as much in-plane and through-plane resolution as
time will allow, should be used to evaluate cartilage, cysts, erosions
and osteophytes. T1-weighted 3D gradient echo images are suited
for quantitative assessment of cartilage, but are probably not ideal
for semi-quantitative assessment since it shows suboptimal
conspicuity in the detection of focal cartilage defects, as demon-
strated in other joints20. Fat suppression21 or selective water exci-
tation are helpful for visualizing the articular cartilage and
subchondral bone marrow alterations22,23. This can be challenging
in the ﬁngers, as irregular shapes perturb magnetic ﬁelds, which
can in turn result in heterogeneous or completely failed spectral fat
saturation or water excitation. Careful calibration of the MRI
magnet for each examination and strategic placement of water bags
can improve this problem in many cases. Short Tau Inversion Re-
covery (STIR) images offer more robust fat suppression, but lack the
spatial resolution required to evaluate small changes in these fea-
tures in ﬁnger joints. STIR images are highly sensitive for evaluatingeophytes at the base of the ﬁrst metacarpal and the articulating os trapezium (arrows).
head). B. Corresponding T1-weighted fat-suppressed contrast-enhanced MRI shows
ral bone marrow lesions (white arrowheads).
Fig. 2. Severe OA of the DIP joints. Coronal T1-weighted MRI shows large osteophytes
at the ulnar-sided heads of the second and third middle phalanges. In addition there is
a subchondral erosion at the head of fourth middle phalanx visualized as a rounded
hypointense lesion on T1-weighted imaging (arrowhead).
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to indirectly evaluate synovitis and tenosynovitis. Intermediate-
weighted fast (or turbo) spin-echo images with fat saturation ac-
quired with relatively thin slices (2e3 mm) may also offer an
excellent contrast assessing synovitis, tenosynovitis and bone
marrow. However, fat-suppressed, T1-weighted sequences
following intravenous gadolinium-based contrast agent should be
ideally performed for the detection and quantiﬁcation of synovitis
and tenosynovitis, and also helps distinguish bone marrow lesions
from erosions and cysts because of superior resolution (Fig. 1)13.
If contrast-enhanced MRI is used, care should be taken to
exclude patients with renal insufﬁciency to minimize the risk of
nephrogenic systemic ﬁbrosis. The current recommendation for
clinical practice is to exclude patients with glomerular ﬁltration
rate (GFR) < 30 mL/min/1.73 m2. For clinical research, higher
thresholds, closer to 60 mL/min/1.73 m2, are often used24.Fig. 3. Representative clinical MRI in a person with hand OA. A. Coronal fat-suppressed pr
Coronal T1-weighted MRI depicts small osteophytes, subchondral sclerosis and cartilage loRecently, compositional MRI techniques have also been intro-
duced to assess biochemical changes within the cartilage of ﬁngers
these are difﬁcult and time consuming. First reports have focused
on the delayed gadolinium enhanced MRI (dGEMRIC) technique
but other techniques may be of use as well25,26. These techniques
may be useful for evaluating early changes in articular cartilage
before signiﬁcant morphological destruction has occurred. At pre-
sent, however, compositionalMRI techniques have not been used in
clinical trials due to challenges applying them consistently in
multicenter settings and because of limited data on validation.
In the end, any MRI protocol must be optimized around the
scientiﬁc objectives and unique practical constraints of the speciﬁc
study in question, particularly with respect to the study centers,
which usually have different equipment, internal processes and
local cultures to consider (Fig. 2). It is difﬁcult, therefore, to deﬁne
in great detail a basic imaging protocol that can be generalized to
all studies. In the opinions of the authors, however, a longitudinal
multicenter study of OA in the ﬁngers would ideally use 1.5T MRI
with a positioning frame and a surface coil or a knee coil if
additional joints will be included. Pulse sequences should include
sagittal and coronal, T1-weighted, 3D gradient-echo scans with
fat-suppression or water excitation and at least 350 m  700 m in-
plane and 1500 m through-plane resolution, coronal STIR
(470 m  470 m in-plane and 3000 m through-plane resolution) and
if possible axial T1-weighted, 3D gradient-echo with fat-
suppression or water excitation following intravenous contrast
administration (1170 m  470 m in-plane and 2000 m through-plane
resolution). If contrast is not included, axial STIR (1170 m  470 m
in-plane and 3000 m through-plane resolution) should be used
instead (Fig. 3).Ultrasound
Ultrasound can be used in OA to visualize osteophytes, synovitis,
effusions and erosions. Positioning and interpretation of ultrasound
imaging of the hand is an interactive process with the ultrasonog-
rapher using visual feedback to scan the areas of interest.Many joints
can be individually imaged providing increased coverage. In addition
to grey-scale ultrasound imaging, power Doppler (Fig. 4) can be used
to assess neovascularity in inﬂammatory arthropathies and erosive/
inﬂammatory hand OA. A multi-frequency linear transducer, typi-
cally 8 MHZ up to 17 MHZ is used to evaluate hand joints.oton density-weighted MRI reveals a small subchondral cyst in the third PIP joint. B.
ss in multiple joints including thumb IP, second DIP and third PIP joints.
Fig. 4. Quantifying power-Doppler ultrasound over 36 frames of acquisition of the metacarpophalangeal joint.
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Radiography
Challenges in radiography have to do primarily with the pro-
jectional viewing perspective of the technique. Since even slight
variations in hand positioning or of beam centering or angulation
among serially acquired images can obscure or reveal osteophytes,
erosions and other structural abnormalities or simulate joint-space
narrowing, meticulous care must be taken to ensure reproducible
projection. Additionally, the shift from ﬁlm-based to digitally ac-
quired radiography has complicated multicenter, longitudinal an-
alyses. These challenges, along with problems related to right-left
mislabeling, are discussed in detail in “Recommendations for
Clinical Trials.”MRI
Positioning within the MR system is crucial to achieve adequate
chemical fat saturation. Therefore the preferred position is that of
the “Superman”positionwhere the patient lays proneheadﬁrst into
the MR system bore with their hand palm side down above their
head. This allows the hand/wrist to be positioned at the isocenter of
the magnet providing superior fat saturation when needed. How-
ever this can be an uncomfortable position. If the study protocol is
not too extensive and the total examination time can be kept short,
e.g., 30e45 min, this usually is not a problem. However, if the ex-
amination is prolongedor thepatient is in toomuchpain, thepatient
can be imaged in the more comfortable “off-center” position, in
which the patient enters the MR system supine and head ﬁrst with
the arm at the side. The problemwith this position is that since the
hand is in the periphery of the magnet bore, where the magnetic
ﬁeld is less homogeneous, signal-to-noise ratio (SNR) is typically
poorer and spectral fat saturation or selective water excitation
needed to identify edema might not be optimal. Other techniques
for fat suppression, such as inversion recovery (STIR), tend to be less
affected by ﬁeld heterogeneities, and therefore may be a better
choice under such conditions. Hence, thought must be given to the
trade-offs among comfort, robustness and efﬁciency when
designing an imaging protocol for clinical research.
Typically circumferential MR coils for the wrist are quite small,
providing coverage of only the wrist, but achieving high SNR. Sur-
face coils aremore versatile, but still commonly restricted to ﬁeld of
views allowing anatomical coverage of only the wrist or the ﬁngers
of the hand but not both. Coil technology has advanced over the
years with the introduction of phased array conﬁgurations that
provide extremely high SNR, and allow knee coils or other large
coils to image both the hand and wrist simultaneously. Most MRcoils are of receive-only type, which increases the Speciﬁc Ab-
sorption Rate (SAR) since the body coil must be used to transmit.
There are speciﬁc transmit/receive coils for the knee and wrist
which not only reduce SAR but allow faster imaging times and
increased SNR employing smaller echo times, which can be
important for acquisitions like T2 mapping.
The most commonly encountered problem besides positioning
and anatomical coverage is poor fat saturation. This is because the
irregular shape of the hand perturbs the magnetic ﬁeld irregularly,
and since resonant frequency is dependent on ﬁeld strength, spec-
tral fat suppression techniques based on pre-irradiating the ﬁeld of
viewwith the average frequency of fat (chemical fat saturation), will
fail in certain locations, usuallyat theﬁngers or other protuberances,
where the frequency of fat has shifted, leading to heterogeneous fat
saturation. The same is true of selectivewater excitation. Incomplete
fat saturation artifacts can be minimized by carefully shimming the
magnet with the hand in the bore, reducing the anatomical irregu-
larities by strategically placing water bags or other volume supple-
ments over or between the ﬁngers, or by using more robust fat-
suppressing pulse sequences, such as inversion recovery.
Ultrasound
In ultrasound each joint has to be evaluated separately and with
different ultrasound modalities such as gray scale, power Doppler
and real time change in position; this increases volume of data
which comes at the expense of time. Therefore operator experience
is crucial as well as trying to establish reproducibility when imag-
ing is done at multiple sites using equipments of various manu-
facturers. Images can be quantiﬁed based on intensity and number
of voxels that are present. This can be performed on the instrument
andwith ofﬂine specialized analysis tools. One of themajor issues is
the centralization of reading and analysis of images. Since acqui-
sition is operator dependent the image capture protocol (joints and
position analyzed) need to be standardized, each imaging facility
should indicate in its policy and standard procedure measure.
Standard procedure images should be recorded, and standard plus
additional images should be stated in the report when recorded
such as ﬁndings with additional imaging characterization (power
Doppler, harmonics, elastography and etc). for any central reading
for large clinical trials.
Quality assurance/Control procedures
Radiography
A handmap or specially designed positioning frames that ensure
the correct right-left labeling of the hand should be provided to each
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tency of hand positioning among centers. In order to assure a
standardized technique, data on the initial radiograph should
include type of radiographic ﬁlm, type of radiographic cassette, ki-
lovolts, milliseconds, and milli-amperage. These should be identical
in subsequent studies. For all trials, the radiographs should be
masked for the patient name and the radiograph should be identi-
ﬁed by a code. Unless there is a special reason, the ﬁrst carpome-
tacarpal (CMC-1) joint does not need to be imaged separately4.
For both symptom and structure-modifying trials, the pre-study
ﬁlms should be evaluated, prior to entry into the study, to conﬁrm
the diagnosis and deﬁne eligibility4. For structure-modifying trials,
all ﬁlms from a single patient should be evaluated at the same time
after the ﬁnal ﬁlms have been obtained. Although blinding to
sequence is the convention right now, its necessity has been
questioned. For most studies, the radiographs of each patient are
presented to the readers in random order, with the date of acqui-
sition masked, so as to blind the readers to visit sequence. This is
particularly important in longitudinal trials without placebo- or
inactive-comparator control. However, some argue that blinding to
sequence is not necessary in studies that include inactive control as
long as the readers are blinded to treatment allocation, and that
reading with known chronology under such circumstances may
even improve sensitivity to change27. However, in studies that show
progression in all treatment arms but no discrimination among
them, unless the readers were blinded to sequence, one cannot be
sure that the progression was not based entirely on bias and
therefore that there was no potential for discriminating treatment
effect in the ﬁrst place, i.e., type-2 error. Thus, the decisionwhether
or not to blind to sequence must be made with care. Further, if the
protocol allows the readers to be aware of the time sequence, this
potential source of bias should be identiﬁed in the protocol, and an
appropriate explanation and justiﬁcation provided. For intra-reader
reproducibility, a pre-speciﬁed number of pairs of baseline and
endpoint radiographs should be re-read at each session and be-
tween sessions. Re-reading anything less than all of cases usually
does not offer sufﬁcient power to discriminate a meaningful
discrepancy, so the value is usually not informative. Since the re-
read sample size usually needs to be all or close to all of the
cases, to be meaningful, one might as well use two readers. Re-
reading of radiographs allows calculation of the intra-reader
cross-sectional and longitudinal variability. If there is more than
one reader, inter-reader variability should also be calculated using
the same sample pairs of radiographs. In Phase III pivotal studies in
other therapeutic areas using nominal or semi-quantitative scoring
methods, the regulatory agencies (FDA and EMA) usually have 100%
of all radiographs read by two readers and a third reader adjudicate
any differences between the ﬁrst two. This is therefore recom-
mended for clinical trials of OA as well.
Before starting the readings, the readers should train together
with the same radiographs to identify and hopefully resolve major
discrepancies and inconsistencies in the way each reads. Studies
have shown that there are variations in the threshold for deﬁning
pathological ﬁndings even among expert readers28e30 and that
variability is minimized when each subject's radiographs are
assessed at the same time31. In multicenter studies, initial recruit-
ment radiographs are sometimes read by site readers to determine
subject eligibility. It is critical in such cases that the site readers also
be trained and validated prior to beginning. Such training can be
performed by expert readers from the core laboratory where the
efﬁcacy readings will be conducted. A preferable alternative is to
have the ﬁlms centrally read to avoid false positive patients from
diluting the cohort. Once the patients are recruited, all radiographs
should be read by centralized reader(s) in order to contain mea-
surement variability.MRI
The image quality goals for MRI of the hand in OA are 1) com-
plete anatomical coverage (both in-plane and through-plane), 2)
absence of artifacts obscuring regions of interest, 3) homogeneous
signal with adequate contrast-to-noise ratio and spatial resolution,
4) identical contrast and resolution among serially acquired images,
and most importantly, 5) identical tomography among serially ac-
quired images. The latter is particularly important for accurately
identifying small changes between visits. Since the hand contains
24 independently mobile bones, no matter how meticulously the
tomographic sections are aligned at each visit, each bone will be
sectioned slightly differently each time unless its position relative
to the other bones is ﬁxed in a reproducible way. The hand must
therefore be immobilized with a positioning frame19 and the space
around the frame and hand ﬁlled with rubber sponge to ensure
extension of the ﬁngers and to reduce motion14. Further, MRI sec-
tions should be carefully aligned in both orthogonal planes using
reproducibly identiﬁable anatomical landmarks. Hardware and
pulse sequences should not be changed between visits.
Careful central monitoring of image quality is highly recom-
mended. As noted above, reproducibility of between-visit align-
ment of tomographic anatomy and therefore slice orientation is
particularly important for accurate, sensitive assessment of change.
As was the case for radiography, MRI readers must be trained on
the scoring method to be used and work together to calibrate their
readings prior to initiating study readings, so as to minimize vari-
ability. All images should be centrally read by two independent
readers blinded to treatment allocation and usually to visit order.
Some percentage of the largest discrepancies between the two
readers’ scores for all or some features can be adjudicated by a third
independent reader who was previously calibrated to the original
two readers. If such a third reader is not available, as is often the
case with novel reading methods, adjudication can be performed
by consensus review of the discrepant cases by the original two
readers. The latter approach has been used in the majority of ran-
domized controlled MRI trials of RA reported thus far.
Ultrasound
Ultrasound is operator dependent, and it is likely the same
operator is not able to acquire all the ultrasounds in the trial. Thus
standardizing the sequence and order of images acquired will help
if different operators are involved. Using the same equipment and
transducer should also help to enhance the homogeneity of images.
Measurement methods
Radiography
Semi-quantitative scoring
Several scoring systems for assessment of radiographic hand OA
have been developed. The scales differ in assessed joints and
whether they provide a global estimation of OA or assess individual
features. Currently, there is no consensus on the preferred scale.
The Kellgren and Lawrence (KL) scale published in 195732 was
the ﬁrst proposed scoring system for hand OA, and is still the most
widely used33. The scale provides a global score of OA severity (0-4
scale, of which grade2 represents deﬁnite radiographic OA) based
on the presence/severity of osteophytes/ossicles, joint space nar-
rowing (JSN), sclerosis of the subchondral bone, pseudocystic areas,
and altered shape of bone ends32 for each joint (MCPs, PIPs, DIPs,
thumb base, i.e., trapeziometacarpal and scaphotrapezial). In 1963
the authors published an atlas with radiographic images and leg-
ends describing the features in each particular ﬁlm34. The
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 732e746738interpretation of the scoring system has been complicated by
different written deﬁnitions of the grades across joint groups as
well as different descriptions in various publications. Further, the
KL scale has been criticized for too much emphasis on osteo-
phytes35, as narrowed/sclerotic joints cannot be classiﬁed as having
OA unless osteophytes are present. Thus, several studies have used
modiﬁed KL scales to overcome these deﬁciencies.
Other scoring systems with detailed assessment of individual
hand OA features have been developed in order to address the
deﬁciencies of the KL scale and optimize agreement36e38. Among
these, the Osteoarthritis Research Society International (OARSI)
atlas published in 1995 (revised in 2007) is most commonly
used37,38. With this atlas as a reference, the presence/severity of
individual features such as osteophytes, JSN, subchondral erosions
(pseudowidening), cysts, subchondral sclerosis, and malalignment
are assessed on semi-quantitative scales. A grading system has
been proposed by Kallman36 assessing six features: osteophytes,
JSN according to a 0e3 scale and sclerosis, cysts, lateral deviation
and erosion in presence/absence.
Other scoring systems have been proposed, but have hardly
been used in any studies after publication. Lane et al. proposed a
new global scale for presence and severity of hand OA39. A sum-
mary grade (0e2 scale) was derived directly from the assessment of
osteophytes and JSN according to a modiﬁed Kallman scale36.
Similarly, Kessler et al. proposed a global scale for presence (not
severity) of hand OA based on osteophytes, JSN and sclerosis ac-
cording to the OARSI atlas37,40. Both the Lane and Kessler scales
gave more emphasis on JSN in comparison to the KL scale, and did
not include other radiographic features such as cysts/erosions and
deformity in the deﬁnition of hand OA.
Verbruggen et al. developed two numerical scoring systems for
the progression of erosive and non-erosive hand OA41,42. The ﬁrst
scoring system, the anatomical lesion progression system, was
based on changes in osteophytes, JSN and cysts (±0.5 point for in-
crease/decrease in size and ±1 point for appearance/disappear-
ance). The systemwas limited by no evaluation of the magnitude of
change. Further, they noticed that joints that developed erosions
often had increasing joint space width (JSW), and therefore got
negative scoring values despite disease progression. Hence, they
developed the anatomical phase progression system to comprise
the erosive evolution. This scoring system was based on an
assumption of hand OA as a disease that undergoes predictable
phases; in the non-erosive stationary phase (S phase), the joint has
classical hand OA features such as osteophytes, JSN, and sub-
chondral bone changes. When the joint progresses into the
destructive phases, the joint space completely disappears (J phase),
and thereafter the subchondral plate becomes eroded (E phase).
These destructive phases are then followed by repair or remodeling
(R phase). Recently, Verbruggen et al. also proposed a more com-
plex scoring system; the Ghent University Scoring System (GUSS),
which has shown higher sensitivity in detection of progression
during the destructive phases43. In GUSS, the proportions of normal
subchondral bone, subchondral plate and joint space are assessed
on an 11 point rating scale (range 0e100 with 10 unit increases).
Quantitative measurement
Image processing software methods can be used to provide fully
quantitative assessment of structures on radiological images. These
measurements rely less on reader subjectivity than semi-
quantitative scoring systems. Much of the earlier work in the
ﬁeld addressed measuring the loss of JSW to assess
RA progression12,44e47. Most of the methods include software that
puts a grid (mesh) over the hand x-rays and calculates the distance
of joint space. More recently thesemethods have been evaluated on
OA subjects to measure reliability9, correlation with semi-quantitative scoring48, and in a caseecontrol study, a comparison
to clinical features49. With these techniques the software auto-
matically delineates the opposing margins of the joint and calcu-
lates the JSWas the distance between the bone margins. Since both
OA and RA cause loss of joint space, software methods developed
for RA can be applied to the OA hand, although the commonly
involved joints are different for the two types of arthritis, and the
presence of osteophytes in the OA joint may require special
consideration. The only problem with these computer-based
methods of measuring JSW is that whilst they offer a quantita-
tive, reliable, and more objective means by which to assess JSN in
patients with RA, they tend to be very time consuming, which has
limited their clinical use12.
MRI
In a study with IV contrast MRI has higher sensitivity to detect
osteophytes and erosions than conventional radiography, and also
synovitis50. On MRI, osteophytes are detected as abnormal bone
protuberance at joint margins or surfaces on T1-weighted fat-
suppressed sequence13,14. Erosion can be detected as a sharply
marginated bone lesion with typical signal characteristics (i.e.,
increased signal intensity in the area of cortical bone and bone
marrow fat on T1-weighted fat-suppressed images)13,14. Synovitis
can be detected as an area in the synovial compartment that shows
post-contrast enhancement of a thickness greater than thewidth of
normal synovium13,14.
Haugen et al. proposed a comprehensive MRI scoring system
and atlas for hand OA (Oslo hand OA scoring system), including
how to assess osteophytes, JSN, erosions/attrition, cysts, mala-
lignment, synovitis, ﬂexor tenosynovitis, bone marrow lesions
and collateral ligament abnormalities14. Most features were
scored on 0e3 scales in the proximal and distal part of the joint
separately, if applicable. Cysts, malalignment and collateral liga-
ment abnormalities were scored as absent/present14. The scoring
system covers the distal and PIP joints, and future studies should
examine whether the scoring system can be similarly applied to
the metacarpophalangeal and thumb base joints. Haugen et al.
found good intra- and inter-reader reliability for the majority of
hand OA features in the scoring system14. Using the same scoring
system, good reliability was also conﬁrmed in another cohort51,
suggesting that MRI can reliably assess OA pathology in the small
ﬁnger joints.
The scoring system was comprehensive in order to include all
potentially relevant features in hand OA. However, the authors
have discovered that certain features, such as collateral ligament
pathology and ﬂexor tenosynovitis, were infrequently present, did
not correlate with OA severity and/or were not associated with
pain in the Oslo hand OA cohort15,50. Hence, based on this expe-
rience, the scoring system was further optimized by the MRI in-
terest group in the Outcome Measures in Rheumatology
(OMERACT)13. OMERACT HOAMRIS13 is a semi-quantitative
scoring system for hand OA features that was iteratively devel-
oped based on Oslo hand OA MRI scoring system published in
201114. The changes made by OMERACT included exclusion of
collateral ligament pathology and ﬂexor tenosynovitis, scoring of
the joint as a whole (i.e., not the distal and proximal part sepa-
rately) and adding half scores (0.5 increments) for bone marrow
lesions, synovitis and erosions in order to better capture small
changes in longitudinal studies.
Ultrasound
In order to facilitate a reliable scoring of ultrasound features in
the ﬁnger joints, a preliminary scoring system was developed.
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synovial hypertrophy/effusion, power Doppler activity and osteo-
phytes. All features were scored as absent/present as well as on
semi-quantitative scales (grade 0e3)52. A large “real-life” reliability
exercise was arranged in order to test the reliability of the proposed
scoring system. Despite divergent results between ultrasonogra-
phers and for the various features (in general lowest reliability for
power Doppler activity and highest for osteophytes), the authors
concluded that the results were satisfactory and that the scoring
system could be a good basis for further development of ultrasound
as an outcome tool.
To facilitate the scoring of osteophytes, Mathiessen et al.
developed an atlas showing examples images of different grades of
osteophyte severity in the interphalangeal joints (grade 0e3)53.
Using the atlas for scoring of stored ultrasound images, the authors
found excellent inter-reader reliability. There is currently no pub-
lished atlas for assessment of grey-scale synovitis and power
Doppler activity in hand OA. However, the synovitis found in OA
can be scored according to the published comprehensive ultra-
sound atlas for grey-scale synovitis and power Doppler activity in
RA54.
The ﬁrst scoring system by Keen et al. did not include assess-
ment of erosions and JSN due to concerns about reliable deﬁnitions,
contemporary ultrasound technology and feasibility related to the
duration of the scanning52. Recently, deﬁnitions of cartilage pa-
thology in the metacarpophalangeal joints were proposed: 1.
Global cartilage abnormalities (absent/present); 2. Loss of anechoic
structure and/or cartilage thinning; 3. Irregularities and/or loss of
sharpness of >1 cartilage margin55. Results from a “real-life” reli-
ability exercise showed varying inter-reader reliability from fair
(irregularities and/or loss of sharpness of) to very good (global
assessment). A further limitation of the system is the focus on
metacarpophalangeal joints only, which are less frequently affected
by OA.
Measurement performance: reliability, responsiveness,
validity
Radiography
As mentioned earlier, the most commonly used semi-
quantitative radiographic scoring methods for hand OA are KL
grading32, VerbruggeneVeys (anatomical phases)42 and Kallman36
grading systems, and the OARSI atlas37,38. They vary regarding
radiographic features and joints assessed. Two recent comparison
studies29,30 of patients followed over 1 and 6 years, respectively
found no real performance difference among these methods. In
fact, KL, which is a global rather than feature-based score, showed
the greatest change, although this scoring systemwas not designed
for assessing change. A further systematic review evaluated
discrimination (reliability, sensitivity to change), feasibility and
validity of the available radiographic scoring methods and found
comparability across studies and called for a consensus on
preferred scoring method, the examined joints and the used pre-
sentation of data (Visser et al. O&C in press). In addition, none of
these scoring methods, except the Verbruggen anatomical phase
scoring system has been developed and validated to be analyzed as
a global scoring summing scores of all hand joints into one global
score (patient level). Whether this is appropriate rather than
considering and analyzing each score at the joint level remains an
open issue.
Quantitative radiographic methods have demonstrated good
reliability9, substantive correlation with semi-quantitative
scoring48, and in a caseecontrol study, a good correlation to clin-
ical features49.MRI
OMERACT HOAMRIS13 is a semi-quantitative scoring system for
hand OA features that was iteratively developed based on the Oslo
hand OA MRI scoring system published in 201114. Haugen et al.
found good intra- and inter-reader reliability for the majority of
hand OA features in the scoring system14. Using the same scoring
system, good reliability was also conﬁrmed in another cohort51,
suggesting that MRI can reliably assess OA pathology in the small
ﬁnger joints. These studies have also shown that MRI can reliably
assess most OA features, including structural changes as well as
inﬂammation, with the current technology14,51. Although good
reliability has been shown in cross-sectional studies14,51, longitu-
dinal studies using MRI in hand OA are needed to examine the
reliability of serial assessments as well as the sensitivity to change
of the MRI features.
Ultrasound
Recent studies have provided insight on the validity with an
association with clinical features, such as pain56 or radiographic
and MRI feature57e60 and with radiographic progression over
time61. Ultrasound has been shown to be more accurate to detect
osteophytes and erosions in hand OA than conventional
radiographs53,58,59.
Recommendations for clinical trials (Table I)
General comments
The goals of imaging in clinical trials can include subject selec-
tion, monitoring disease progression and treatment effect, and/or
identifying complications of the disease or the treatment. An im-
aging biomarker may be excellent for diagnosis but not useful for
monitoring disease progression. To be applicable to the latter, the
biomarker must change over time. For example, the presence of a
particular receptor in certain joint tissues may be critical to a pa-
tient's responsiveness to a treatment speciﬁcally targeting that
receptor. Perhaps one could use a radiolabeled probe for that re-
ceptor using scintigraphy or PET to identify patients applicable to
the therapy. However, if the receptor itself doesn't change in
response to the treatment, the imaging technique cannot be used to
monitor response. In the case of hand OA, the presence of osteo-
phytes in the DIP/PIP joint or CMC-1 joint at the base of the thumb,
are important for diagnosis, but it is not clear how changes in
osteophyte size relate to clinical outcomes, besides cosmetically. It
is possible that osteophyte formation actually represents an adap-
tive, potentially beneﬁcial response to OA, and that removal or
suppression of osteophytes under certain circumstances could be
deleterious. Alternatively, a biomarker that normally can be used to
monitor disease progression or treatment response, such as carti-
lage loss or JSN, can become useless if it has reached its ceiling, and
cannot progress further. Thus, severity of such an otherwise
responsive marker could serve as a criterion for excluding patients
from certain studies. The same could be said for subchondral bone
attrition or erosion. Once morphological distortion is too great and
becomes a signiﬁcant driver of further damage itself, some treat-
ments may lose efﬁcacy.
With respect to monitoring disease progression or treatment
response, not only does the linkage between changes in the
biomarker and how patients feel and function matter, but also the
power with which the biomarker discriminates change. This relates
to the actual rate of change of the structure or process that the
biomarker targets, but also to the effect size and the measurement
error. The latter includes variability introduced during image
Table I
Summary of recommendations for clinical trials
Process Strength of
recommendation
(range 0e100)*
Site technologists should receive training on
study-speciﬁc imaging technique, the quality of their
images should be centrally veriﬁed and regular
feedback provided
95
Patient-grouped images from multiple visits should be
viewed simultaneously, blinded to treatment
allocations and usually to chronological order as well
72
Readings should be performed centrally by two
independent readers, and adjudicated
79
Readings should be performed by a musculoskeletal
radiologist
49
Radiography
Each hand should be imaged separately 56
Standardized, reproducible positioning, beam centering
and exposure are critical
83
Acquisition should include the use of a positioning
frame
69
Regarding scoring methods, consistent with the
consensus from OMERACT 12 we encourage use of
the most widely used and currently best validated
measures in a core set for structural damage. We
would advocate use of either the KellgreneLawrence
method, or the OARSI atlas or the VerbruggeneVeys
method or the Kallman method, as preliminary
instruments for the structural damage domain.
83
MRI
Coverage should include the ﬁngers, especially DIP and
PIP joints, and possibly CMC-1
91
Reproducible tomography is critical including the use of
an acrylic positioning frame and biplanar slice
alignment
72
Triplanar sections are ideal, but if not feasible, coronal
and possibly sagittal sections should be acquired
89
Pulse sequences should include STIR and high-
resolution, fat-suppressed 3D gradient echo ± post-
contrast T1-weighted sequence
83
Most developed reading method today is HOAMRIS and
we would recommend its use in MRI trials
84
* Mean response from the 14 persons on the working group who responded to
the survey. Results of participants who were conﬂicted are not included. Strength of
recommendation scale ranged from 0 (don't recommend) to 100 (strongly
recommend).
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 732e746740analysis but also that introduced during image acquisition. Vari-
ability stemming from the images themselves is minimized by
judicious protocol design and meticulous quality control, including
technologist training, ongoing image quality veriﬁcation, and
repeat imaging whenever needed. Variability associated with im-
age analysis is contained by using central readers (ideally two) who
are specially trained, calibrated to each other and highly experi-
enced in reading for clinical trials, and by using reading worksta-
tions that optimally display the serial scans, minimize data entry
errors and limit reader fatigue.
Safety monitoring with imaging depends on the mechanism of
action of the intervention, but may include looking for signs of
osteonecrosis, infection or stress fracture.
Explicit decisions about any of these factors depends on the
scientiﬁc, regulatory and business objectives of the study as well as
practical considerations, such as patient tolerance and safety, pa-
tient availability, time to market goals and budgetary constraints.
Central to all of these is the role that the project will play in the
treatment development program. Design considerations are very
different if the study is a pivotal phase-III trail intended to establish
deﬁnitive proof of efﬁcacy and safety for regulatory approval, than
if the intention is to inform internal decision making and portfolio
management, such as in phase-II proof of concept or studies aimedat determining how subsequent phase-III trials should be designed
with respect to patient type, biomarker type, sample size, follow-up
interval, intensity of quality control, etc. Phase-IV studies that
explore special circumstances, such as patient subtypes or different
practice settings similarly entail different protocol design tradeoffs.
Image acquisition and quality control
How the images for a study will be analyzed, including the
particular biomarkers that will be used and the strengths and
preferences of the readers who will perform the readings, ulti-
mately dictates how the images should be acquired and the speciﬁc
quality criteria that must be prioritized. No matter how experi-
enced, skilled and dedicated the readers for a clinical trial may be,
their readings can only be as accurate and sensitive to change as the
quality of the images is able to support. Thus, image quality can
make or break a trial. Unlike in clinical practice, images for clinical
trials are acquired frommultiple different sites, often from different
countries, each with different hardware, software, local processes,
languages and cultures, and the images from these diverse facilities
must be pooled with no discernable differences among them
except those related to the patients and the treatments. There is no
other context in radiology in which this is necessary, and it is thus
counterintuitive to clinical radiologists and technologists, who have
been taught to optimize image acquisition around individual pa-
tient idiosyncrasies, local hardware/software strengths and weak-
nesses, and their local radiologists’ preferences. Each cohort of
imaging sites included in a study poses unique challenges to
designing an imaging protocol that accomplishes uniform image
quality, and thus it is difﬁcult to generalize. Designing such pro-
tocols require in depth multivendor technical knowledge as well as
an understanding of how radiology departments function in
different parts of the world.
Once the imaging protocol is decided on, site technologists must
be instructed on the procedure, particularly why the imaging pro-
tocol was designed the way that it was, what elements of the
protocol are most important to accurate image analysis and
therefore require the most attention, and how to avoid and solve
problems that may arise. How this information is conveyed de-
pends on the experience and motivation of the technologists
involved, but typically involves a combination of printed manuals
and didactic or interactive training sessions conducted in groups or
one-on-one by webinar or face-to-face meetings. Test scans with
volunteers or even phantoms can be helpful, but continuous feed-
back on quality and acquiring repeat scans when necessary, if
feasible, are critical elements of a successful training/quality control
program.
As outlined in “Acquisition Methods/Techniques-Guidance on
positions for radiography, sequence/protocol recommendations/
hardware for MRI,” radiography of each hand should be performed
independently with the hand positioned palm down and ﬂat and
the ﬁngers fully extended. Measures should be taken to ensure that
the right and left hands are accurately labeled. Image labeling can
be unreliable if radiopaque markers are place on the ﬁlm-screen
manually. Key radiographic image quality considerations are com-
plete anatomical coverage, reproducible projection of the joint
spaces and bones among serially acquired images, absence of ar-
tifacts obscuring target locations, and sharp delineation of cortical
and trabecular bone. Once screen-ﬁlm based radiographs are felt to
be of adequate quality by the radiology technologist, they should be
digitized to 100 m pixel spacing, and graphic quality veriﬁed cen-
trally using uniform criteria.
Recently, there has been a trend at most clinical facilities away
from screen-ﬁlm radiography to digital radiographic acquisition.
While this has been a positive change for image archival, patient
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and variability to multicenter clinical trials. Not only is the spatial
resolution of digitally acquired radiographs generally lower than
that of images generated by digitizing originally ﬁlm-based radio-
graphs, verifying the quality of digitally acquired radiographic im-
ages is harder for technologists. In the past, technologists could
visually inspect ﬁlm radiographs directly on backlit view boxes.
However, digital radiography generates 12-bit electronic images
comprising 4096 grayscale units. Since the human eye can
discriminate only a small fraction of these, technologists must infer
image quality indirectly from the exposure index, which is a
parameter that is computed differently by different manufacturers.
Not only has this added technical variability to multicenter clinical
trials, but, because some imperfections in digital image quality can
be corrected through post-processing by the reading radiologist
after the patient has left, the focus of radiology technologists at
busy medical centers has shifted from meticulous image acquisi-
tion to rapid patient throughput. Unfortunately, reproducible pa-
tient positioning on serial radiographs, which is critical for reliably
assessing change in clinical trials, cannot be corrected by digital
post-processing. Accordingly, studies employing digital radiog-
raphy must invest additional effort to ensure uniformity and high
quality of images pooled from multiple sites.
As outlined in “Acquisition Methods/Techniques-Guidance on
positions for radiography, sequence/protocol recommendations/
hardware for MRI,”MRI of the hand should employ an acrylic frame
that ﬁxes the position of the ﬁngers and hand properly and
reproducibly. It should also include meticulous biplanar alignment
of slices using reliable anatomical landmarks to ensure reproduc-
ible tomography of the bones and joints on serially acquired scans
in longitudinal studies. Anatomical coverage should include at least
the ﬁngers, particularly the DIP and PIP joints. This can be accom-
plished with most commercial surface coils. If the CMC-1 joint is of
interest, which currently is not formally included in HOAMRIS, two
separate scans with surface coils or a single scan with a knee coil
will be needed. Ideally, high-resolution, fat-suppressed, T1-
weighted, 3D gradient-echo scans in all three orthogonal planes
should be acquired. However, if this is not feasible because of time
constraints, as is usually the case, coronal and possibly sagittal
scans should be acquired to assess osteophytes, cartilage loss and
subarticular cysts/bone erosions. To evaluate bone marrow lesions
and synovitis, coronal STIR or fat-suppressed intermediate-
weighted spin echo scans should be included. These generally
lower-resolution pulse sequences could be substituted with
contrast-enhanced fat-suppressed, T1-weighted, 3D gradient-echo
scans, which are more reliable for synovitis assessment. However,
gradient-echo techniques are less sensitive for bone marrow le-
sions evenwith enhancement. Thus, the decision between STIR and
contrast-enhanced 3D gradient-echo depends on the relative
importance of synovitis and bone marrow lesions to the study
objectives. Tendons and synovitis are best assessed in the axial
plane. As noted above, contrast-enhanced 3D scans are optimal for
synovitis but due to time constraints, STIR is often the most feasible
option for axial scanning.
As detailed in the section on Quality Assurance/Control Pro-
cedures, key image quality criteria for MRI include adequate
anatomical coverage, absence of artifacts or signal drop-off in target
locations, adequate tissue contrast and spatial resolution, and
importantly, comparability of cross-sectional anatomy among serial
scans.
Image analysis
Since the experience with clinical trials of hand OA is so limited,
there is no consensus yet onwhich scoring method should be used.As discussed in “Research Recommendations for Hand osteoar-
thritis,” the most commonly used radiographic scoring methods for
hand OA are KL grading32, Verbruggen anatomical phases scoring42,
Kallman scale36 and the OARSI atlas37,38. The most recently devel-
oped MRI scoring method is the Outcome Measures in Rheuma-
tology (OMERACT) Hand OA MRI Score (HOAMRIS)13.
Regardless of the scoring method used, however, readings for
clinical trials should be performed centrally, ideally by two trained
readers experienced in the scoring methods to be used and in
reading for clinical trials of arthritis. As is the standard in RA trials,
serially acquired images for a patient should be displayed simul-
taneously and possibly in random visit order, so that the readers
remain blinded to chronology. This is particularly important in
studies without an inactive comparator arm. Note that re-reading
of some timepoints may be required when interim analyses are
performed in extended, multi-visit longitudinal studies.
Each reader should independently score all images for all patients
on regulatory compliant electronic case report forms (eCRF) without
knowledge of the other readers’ values. Additionally, inmost studies,
cases in which the readers disagree more than a certain degree are
rescored either by a third independent reader or by consensus re-
view by the original two readers. The purpose of this adjudication is
not to statistically smooth variability further, as that would require
re-reading of all of the cases in order to be unbiased, but rather to
identify data entry errors or other mistakes that would be expected
to show up as discrepancies but not related simply to ambiguity of
scoring criteria, as the latter is already dealt with by score averaging.
Regulators are provided both the original and adjudicated results.
Research recommendations
General comments
Clinical research in imaging is often divided into technical
innovation or application development. The two are interdepen-
dent in that development of new capabilities, enhanced perfor-
mance of existing capabilities, or improved convenience,
accessibility or cost-effectiveness can reveal previously unantici-
pated application possibilities, and new or unmet existing needs
drive demand for technological innovation.
In the case of hand OA, one can anticipate a similar course as was
seen in RA, in which imaging has been used successfully in clinical
trials for more than two decades. As was the case for RA 20 years
ago, the current lack of effective structure modifying therapy for
hand OA has limited demand from clinicians for detailed imaging
information about joint structure in these patients. Why determine
whether a patient is an appropriate candidate for a structure-
modifying therapy or whether that therapy is working properly if
the therapy does not yet exist? However, precise and fully validated
methods for doing both of these are necessary to gain regulatory
approval of any putative structure-modifying therapy for hand OA.
Thus, the demand for imaging in this disease, as in most others,
emerges ﬁrst during the clinical development of potential therapies
by pharmaceutical, biotechnology and medical devices companies,
and it is therefore the scientiﬁc, logistical, regulatory and business
needs of the drug development process that shape the early evo-
lution of imaging for hand OA.
Also as for RA, once effective therapies become accessible,
withholding treatment for prolonged periods in placebo controlled
trials becomes unethical. This increases demand for methods that
can discriminate treatment effects more rapidly and sensitively,
both for clinical trials and clinical practice. Further, as the therapies
become available in the clinic, the measurement methods must be
adapted for that context, which differs in a number of ways from
that of clinical trials. In clinical research, there is a greater demand
Table II
Summary of research recommendations (the strength of recommendation refers to
the priority this group gives to this research question/topic)
General comments Strength of
recommendation
(range 0e100)*
Further work on the speciﬁc joint (DIP vs PIP vs CMC-1
vs MCP) to be assessed
79
Conventional radiography
Which structural features (e.g., osteophytes, JSN erosion
etc.) should be assessed?
61
Reliability of longitudinal JSW assessment (including
the reproducibility of radiographic projection)
73
Sensitivity to change (JSW) 78
Timing of imaging assessment(s) (depends on biological
rate of change, which needs to be assessed in
epidemiological studies, sensitivity to change of the
imaging modality and anticipated effect size of the
intervention)
80
Ultrasound
Which structural features and joints (e.g., the CMC-1
may be more challenging to examine than the DIP
joints) could reliably be assessed with the current
technology
63
Methods to optimize variability introduced by operator
dependency
87
Reliability of longitudinal assessment 82
Timing of imaging assessment(s) (depends on biological
rate of change, which needs to be assessed in
epidemiological studies, sensitivity to change of the
imaging modality and anticipated effect size of the
intervention)
70
Sensitivity to change of the ultrasound features 78
MRI
Which structural features could reliably be assessed
with the current technology
85
Protocols for assessment of the interphalangeal and
CMC-1 joint (of which the latter is a complex joint
and could be target for non-systemic treatment)
76
Reliability of longitudinal assessment 90
Sensitivity to change of the MRI features 95
Timing of imaging assessment(s) (depends on biological
rate of change, which needs to be assessed in
epidemiological studies, sensitivity to change of the
imaging modality and anticipated effect size of the
intervention)
84
Use of contrast for assessment of synovitis 69
Additional research questions suggested by survey respondents
Whether paired radiographs of a same patient should be
read in known chronological order or blinded to time
sequence.
Is there sufﬁcient measurement performance data
validatingMRI and ultrasound as imagingmethods in
hand OA that they can replace or supplant the need
for radiography.
How best to analyze the scorings and radiographic
progression; whether at the patient level or joint
level.
The utility of elastography (both on ultrasound and
MRI) as a tool to evaluate musculoskeletal tissues.
* Mean response from the 14 persons on the working group who responded to
the survey. Scale ranged from 0 (don't recommend) to 100 (strongly recommend).
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 732e746742for quantitative data rather than subjective data. Images in clinical
practice must answer questions about the management of indi-
vidual patients, where as in clinical trials images acquired from
multiple different sites must be pooled to answer research ques-
tions applicable to large groups of patients. Imaging for hand OA is
currently in the ﬁrst stage of this development cycle. Accordingly, it
is important to accumulate as much long-term data as possible on
placebo-treated patients while structure modifying therapies are
still not available.
As for RA, radiographic and MRI scoring methods have been
developed for diagnosing hand OA, quantifying the severity ofstructural damage associated with it and for monitoring change
and potential improvement over time, including radiographic
KL32,34 and OARSI37,38 scales, Verbruggen42 and Kallman36 grading
and the HOAMRIS system13. Image-quality requirements for sup-
porting these analyses and thus the protocols for acquiring the
images are in turn driven by the needs and preferences of the ra-
diologists who ultimately will perform the readings.
As in RA, radiographic methods for assessing hand OA devel-
oped ﬁrst. As newer technologies, such as MRI, ultrasound, etc.,
became available, new methods for quantifying disease severity
and change capitalizing on the unique strengths of these in-
novations followed.
Technical optimization is thus needed around each of the
following factors:
 Which disease features should be assessed with each candidate
imaging modality
 Which semi-quantitative scales or quantitative measures should
be applied to each feature, anticipating that the performance
requirements for these biomarkers will likely change once they
have veriﬁed the efﬁcacy of new structure modifying treat-
ments, and these therapies become clinically available
 Strengths and weaknesses of different image acquisition pro-
tocols in multi-site clinical trial settings
Each of these will be addressed below.Radiography
Radiography's strengths in imaging hand OA are high contrast
and two-point resolution for cortical and trabecular bone, wide-
spread availability and technical familiarity, and relatively low unit
cost. Its weaknesses are low contrast for discriminating non-
calciﬁed tissues, projectional viewing perspective, and ionizing
radiation, which for hand imaging is relatively minor. Thus, radi-
ography can visualize osteophytes, bone erosions and cysts, joint-
space width, bone sclerosis and joint alignment in the hand, but
it cannot see articular cartilage directly, bone marrow lesions or
osteitis, synovitis, joint effusion, tenosynovitis, tendons or liga-
ments, all of which are relevant to pain and functional disability in
hand OA, and which can be assessed with MRI (see below). Future
studies should explore to which extent these additional MRI-
visible, disease-based features link to pain and dysfunction in
hand OA, and whether they add substantially more discriminative
power to assessments of disease progression and treatment
response than do the conventional radiographs.
Because it is a projectional rather than a tomographic technique,
and multiple planes are superimposed in one image, radiography
magniﬁes and distorts anatomy. This makes quantitative dimen-
sional measurement more challenging, and necessitates meticu-
lously reproducible hand positioning and projection on serially
acquired radiographs in order to assess change accurately and
sensitively. Projection can also obscure ﬁndings by superimposing
overlying structures. Thus, osteophytes and erosions projected
enface are less sensitively detected than those tangential to the X-
ray beam. Even minimal rotation of the hands or variation in beam
centering and alignment between serial examinations can there-
fore mimic or obscure changes in these features and joint-space
narrowing. These limitations decrease sensitivity to change,
necessitating larger numbers of patients and longer follow-up in-
tervals to achieve statistical power. Moreover, as for RA, the recent
shift from ﬁlm-based radiography to digitally acquired radiography
at most imaging facilities around the world has made high-quality
multi-center radiography of the hand more challenging.
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of assessments needs to be determined. This depends on the
pathological rate of change, which in turn needs to be determined
in epidemiological studies. It also depends on sensitivity to change
of the imaging modality, which in turn depends on the effect size of
the intervention and themeasurement error of the scoringmethod.
Research into each of these would be helpful.
MRI
Very few studies have so far been performed onMRI in hand OA,
and future studies are needed. A few studies have shown that MRI
can reliably assess most OA features, including structural changes
as well as inﬂammation, with the current technology14,51. However,
these ﬁndings should be conﬁrmed in more studies. There are
currently no protocols for how best to assess the ﬁnger joints,
including the interphalangeal, metacarpophalangeal and thumb
base. Furthermore, previous studies have focused on interphalan-
geal joints13,14, and no scoring system is available for the meta-
carpophalangeal joints and thumb base.
Although good reliability has been shown in cross-sectional
studies14,51, longitudinal studies using MRI in hand OA are needed
to examine the reliability of serial assessments as well as the
sensitivity to change of the MRI features.
When it comes to the timing of MRI assessment, it depends on
the biological rate of change, which needs to be assessed in
epidemiological studies, sensitivity to change of the imaging mo-
dality and anticipated effect size of the intervention.
Assessment of synovitis according to the proposed MRI scoring
systems for hand OA requires the use of intravenous gadolinium
contrast13,14. Future studies are needed in order to compare the
sensitivity in detection of synovitis using non-contrast enhanced
images and contrast-enhanced images.
Ultrasound
As with MRI, ultrasound has the capacity to detect inﬂamma-
tion, deformity (osteophytes) and damage (erosions, ligament ab-
normalities). It cannot assess subcortical bone abnormalities
because of acoustic shadowing by cortical bone. For the same
reason, some joint surfaces and synovial cavities in the hand and
wrist are not accessible to US, particularly the ulnar surface of
metacarpophalangeal joint (MCP) 2, the radial surface of MCP 5,
both the radial and ulnar surfaces of MCPs 3 and 4, and the ulnar
surface of the important CMC-1 at the base of the thumb.
Most OA studies using ultrasound have deployed semi-
quantitative assessments and further work is still required on
their basic psychometric properties. Criterion and construct val-
idity may be assumed for synovitis (based on RA studies but also on
osteoarthritic knee biopsy studies), and there has been comparison
between ultrasound and radiographic osteophytes62. Further work
is required on understanding the validity of JSW or cartilage loss
when compared to other modalities. There is a need for more in-
formation on how ultrasound abnormalities relate to clinical
symptoms63 and also for predictive validity64 on most ultrasound-
detected OA pathologies.
Reliability has been examined for a number of scoring sys-
tems52,55, and further work on deﬁnitions and standardized reader
training will be required to improve this area, which underpins
responsiveness. Few studies have examined responsiveness of
various scoring systems65; generally these focus on pathological
features expected to show change.
Use of ultrasound in clinical trials is feasible, though lessons can
be learnt from the more numerous RA trials. As is clear from the
previous discussion, the optimal semi-quantitative score orquantitative tool for (even selected) pathologies is not yet estab-
lished. More work is required to standardize operating procedures
for such studies. As well as understanding and recording inter-
machine differences in pathology detection, studies with multiple
readers or sites require consensus training pre-trial and well
deﬁned deﬁnitions of pathologies, which may reduce sensitivity
while increasing inter-reader agreement66. Issues on timing of
studies will depend on the responsiveness of individual imaging
biomarkers.
Summary and conclusion
The goals of imaging the hand in clinical trials can include
subject selection, monitoring disease progression and treatment
effect, and/or identifying complications of the disease or the
treatment. For acquisition a PA radiograph of each hand on separate
cassettes should be obtained, with the palmar aspect of the hand
placed on the ﬁlm with the ﬁngers extended and adducted on a
positioning frame. MRI protocols must be optimized around the
scientiﬁc objectives and unique practical constraints of the speciﬁc
study in question, particularly with respect to the study centers. For
a longitudinal multicenter study of OA in the ﬁngers ideally one
would use 1.5 T MRI with a positioning frame and a surface coil.
For radiographic studies patient-grouped images from multiple
visits should be viewed simultaneously, blinded to treatment al-
locations. Readings should be performed centrally by two inde-
pendent readers, and adjudicated. This manuscript includes a
number of recommendations for clinical trials that we would
advise anyone planning on using imaging in hand OA follow.
Author contributions
All authors were involved in collecting data, reviewing the
literature and drafting the article or revising it critically for
important intellectual content, and all authors approved the ﬁnal
version to be published.
Disclosure
The comments and editorial expressed herein represent those of
the author/s and do not reﬂect those of any ofﬁcial scientiﬁc role or
institution that the author/s may be hold or be afﬁliated with. The
corresponding author had full access to all the data in the study and
had ﬁnal responsibility for the decision to submit for publication.
Conﬂict of interest
1 David Hunter has royalties from Donjoy for a patent granted
for a patellofemoral buttress. Has a grant from the NIH,
multiple grants from Australian Research Council and
NHMRC. Associate Editor for Osteoarthritis and Cartilage.
2 Nigel Arden e Has a grant from the NIHR for outcomes of
arthroplasty and Biomedical Research Unit, one from NIH for
hip morphology and another one from ARUK for video,
project and equipment. Received honoraria from Bioiberica,
Scherring-Plough, Merck, Servier.
3 Flavia Cicuttini-Has grants from the NHMRC for Statin RCT,
Zolendronic Acid RCT and ACL study and TasOAK cohort.
Holds a volunteered paid position in Repatriation Medical
Authority as a Medical Ofﬁcer, and one as an Associate Editor
in Arthritis and Rheum, BMC Musculoskeletal Journal, and
ART Journal.
4 Michel D. Crema e has shares in Boston Imaging Core Lab,
LLC a company providing image assessment services to
academia and the pharmaceutical and medical device
industry.
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 732e7467445 Bernard Dardzinski e no conﬂict of interest to disclose.
6 Jeffrey Duryea e has a grant from NIH/NIAMS for a Quanti-
tative MRI analysis method for longitudinal assessment of
knee OA.
7 Ali Guermazi receives honorary from Genzyme, TissueGene,
OrthoTrophix and Merck Serono. He has shares in Boston
Imaging Core Lab, LLC. Deputy Editor of Radiology.
8 Ida Kristin Haugen e Has a grant from the Norwegian
Rheumatism Association (Extrastiftelsen) for imaging in
hand OA.
9 Margreet Kloppenburg-received lecture/consultancy fees
from Pﬁzer, Servier, Abbvie, UCB, BMS and has grants from
Dutch Arthritis Foundation, Pﬁzer, TI Pharma, OMERACT, and
is Associate Editor at Arthritis & Rheumatology.
10 Emmanuel Maheu-Has received in the past 5 years honoraria
and/or been invited at congresses from/by Expanscience,
Ibsa-Genevrier, Pierre Fabre Labs, Rottapharm, TRB-
Chemedica. Editorial Board of Osteoarthritis and Cartilage.
11 Colin G. Miller- Senior vice president at Bioclinica.
12 Johanne Martel-Pelletier e receives honoraria from Arthro-
Lab/ArthroVision, Bioiberica, Elanco, Ferring, Merck, Pﬁzer,
Servier, TRB Chemedica. Has grants from The Arthritis Soci-
ety (as co-investigators), Canadian Institutes of Health
Research (CIHR) (as co-investigator). Has investment in non-
medical industry at ArthroLab/ArthroVision and is a Share-
holder. Holds a volunteered lecturer position at the ESCEO13-
IOF European Congress on Osteoporosis and Osteoarthritis
(travel grant).
13 Jean-Pierre Pelletier-receives honoraria from ArthroLab/
ArthroVision, Bioiberica, Elanco, Ferring, Merck, Pﬁzer,
Servier, TRB Chemedica. Has grants from The Arthritis Soci-
ety (as co-investigators), Canadian Institutes of Health
Research (CIHR) (as co-investigator). Has investment in non-
medical industry at ArthroLab/ArthroVision and is a Share-
holder. Holds a volunteered lecturer position at the ESCEO13-
IOF European Congress on Osteoporosis and Osteoarthritis
(travel grant).
14 R. Elena Ochoa Albízteguie no conﬂict of interest to disclose.
15 Charles Peterfy e has shares in Spire Sciences, inc., which
provides Image analysis for clinical trials to multiple phar-
maceutical and medical device companies. He holds a vol-
unteered paid position in The International Society for
Musculoskeletal Imaging in Rheumatology as treasurer.
16 Frank Roemere has shares in Boston Imaging Core Lab, LLC, a
company providing image assessment services to academia
and the pharmaceutical and medical device industry. Asso-
ciate Editor for Osteoarthritis and Cartilage.
17 Garry E. Gold receives honoraria as a consultant from Zim-
mer Inc., Isto, Inc. and Boston Scientiﬁc. Has a grant from GE
Healthcare for improved MR Systems and one from the NIH
for advanced MRI of Osteoarthritis.
Acknowledgments
Dr Hunter is supported by an NHMRC (Grant no. 1079777)
Practitioner Fellowship. Dr Gold is supported by an NIH K24 Grant
(AR062068) and RO1 (EB002524).
We acknowledge the support and contribution of the entire
OARSI Imaging Clinical Trials Recommendations working group
which includes: Ali Guermazi, Bernard Dardzinski, Charles Peterfy,
John Carino, Colin Miller, Diann Stern, Emmanuel Maheu, Felix
Eckstein, Flavia Cicuttini, Frank Roemer, Garry Gold, Hollis Potter,
Ida Haugen, Jean-Pierre Pelletier, Jean-Pierre Raynauld, Jeffrey
Duryea, Joanne Jordan, Johanne Martel-Pelletier, Kim Bennell, Lee
Simon, Marc Hochberg, Margreet Kloppenburg, Michael Nevitt,Michel Crema, Mike Bowes, Nancy Lane, Philip Conaghan, Richard
Kijowski, Roy Altman, Saara Totterman, Siegfried Trattnig, Souhil
Zaim, Thomas Link, Thomas Schnitzer, TimMcAlindon, TimMosher,
Yves Henrotin, Frank Roemer, Goetz Welsch, Graeme Jones, Jordan
Renner, Marie-Pierre Hellio Le Graverand and Nigel Arden. We also
acknowledge the administrative support of Diann Stern.
OARSI gratefully acknowledges support to defer in part the cost
of printing of the Clinical Trial Recommendations from Abbvie,
BioClinica, Boston Imaging Core Lab, and Flexion. The funding
sources for printing had no role in the outcome of this manuscript.References
1. Matthews GL, Hunter DJ. Emerging drugs for osteoarthritis.
Expert Opin Emerg drugs 2011;16(3):479e91.
2. Abramson SB, Berenbaum F, Hochberg MC, Moskowitz RW.
Introduction to OARSI FDA initiative OAC special edition.
Osteoarthritis Cartilage 2011 May;19(5):475e7.
3. Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N,
Bloch DA, et al. Design and conduct of clinical trials in patients
with osteoarthritis: recommendations from a task force of the
Osteoarthritis Research Society. Results from a workshop.
Osteoarthr Cartil 1996 Dec;4(4):217e43.
4. Maheu E, Altman RD, Bloch DA, Doherty M, Hochberg M,
Mannoni A, et al. Design and conduct of clinical trials in pa-
tients with osteoarthritis of the hand: recommendations from
a task force of the Osteoarthritis Research Society Interna-
tional. Osteoarthr Cartil 2006 Apr;14(4):303e22.
5. Schreibman KL, Freeland A, Gilula LA, Yin Y. Imaging of the
hand and wrist. Orthop Clin N Am [Review] 1997 Oct;28(4):
537e82.
6. Bhat AK, Kumar B, Acharya A. Radiographic imaging of the
wrist. Indian J Plast Surg 2011 May;44(2):186e96.
7. Swagerty Jr DL, Hellinger D. Radiographic assessment of
osteoarthritis. Am Fam Phys [Review] 2001 Jul 15;64(2):
279e86.
8. Angwin J, Heald G, Lloyd A, Howland K, Davy M, James MF.
Reliability and sensitivity of joint space measurements in hand
radiographs using computerized image analysis. J Rheumatol
2001 Aug;28(8):1825e36.
9. Huetink K, van 't Klooster R, Kaptein BL, Watt I,
Kloppenburg M, Nelissen RG, et al. Automatic radiographic
quantiﬁcation of hand osteoarthritis; accuracy and sensitivity
to change in joint space width in a phantom and cadaver
study. Skelet Radiol 2012 Jan;41(1):41e9 [Research Support,
Non-U.S. Gov't].
10. Genant HK, Jiang Y, Peterfy C, Lu Y, Redei J, Countryman PJ.
Assessment of rheumatoid arthritis using a modiﬁed scoring
method on digitized and original radiographs. Arthritis Rheum
1998 Sep;41(9):1583e90.
11. Neumann G, dePablo P, Finckh A, Chibnik LB, Wolfe F, Duryea J.
Patient repositioning reproducibility of joint space width
measurements on hand radiographs. Arthritis Care Res 2011
Feb;63(2):203e7 [Comparative Study Research Support, N.I.H.,
Extramural Research Support, Non-U.S. Gov't].
12. Finckh A, de Pablo P, Katz JN, Neumann G, Lu Y, Wolfe F, et al.
Performance of an automated computer-based scoring
method to assess joint space narrowing in rheumatoid
arthritis: a longitudinal study. Arthritis Rheum 2006
May;54(5):1444e50 [Randomized Controlled Trial Research
Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
13. Haugen IK, Ostergaard M, Eshed I, McQueen FM, Bird P,
Gandjbakhch F, et al. Iterative development and reliability of
the OMERACT hand osteoarthritis MRI scoring system.
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 732e746 745J Rheumatol 2014 Feb;41(2):386e91 [Research Support, Non-
U.S. Gov't].
14. Haugen IK, Lillegraven S, Slatkowsky-Christensen B,
Haavardsholm EA, Sesseng S, Kvien TK, et al. Hand osteoar-
thritis and MRI: development and ﬁrst validation step of the
proposed Oslo Hand Osteoarthritis MRI score. Ann Rheum Dis
2011 Jun;70(6):1033e8 [Research Support, Non-U.S. Gov't
Validation Studies].
15. Haugen IK, Bøyesen P, Slatkowsky-Christensen B, Sesseng S,
Van Der Heijde D, Kvien TK. Associations between MRI-
deﬁned synovitis, bone marrow lesions and structural fea-
tures and measures of pain and physical function in hand
osteoarthritis. Ann Rheum Dis 2011 Nov 25.
16. Conaghan PG, Durez P, Alten RE, Burmester GR, Tak PP,
Klareskog L, et al. Impact of intravenous abatacept on syno-
vitis, osteitis and structural damage in patients with rheu-
matoid arthritis and an inadequate response to methotrexate:
the ASSET randomised controlled trial. Ann Rheum Dis 2013
Aug;72(8):1287e94.
17. Kamishima T, Tanimura K, Shimizu M, Matsuhashi M, Fukae J,
Kon Y, et al. Monitoring anti-interleukin 6 receptor antibody
treatment for rheumatoid arthritis by quantitative magnetic
resonance imaging of the hand and power Doppler ultraso-
nography of the ﬁnger. Skelet Radiol 2011 Jun;40(6):745e55.
18. Ostergaard M, Emery P, Conaghan PG, Fleischmann R, Hsia EC,
Xu W, et al. Signiﬁcant improvement in synovitis, osteitis, and
bone erosion following golimumab and methotrexate combi-
nation therapy as compared with methotrexate alone: a
magnetic resonance imaging study of 318 methotrexate-naive
rheumatoid arthritis patients. Arthritis Rheum 2011
Dec;63(12):3712e22.
19. Peterfy CG, Olech E, Dicarlo JC, Merrill JT, Countryman PJ,
Gaylis NB. Monitoring cartilage loss in the hands and wrists in
rheumatoid arthritis with magnetic resonance imaging in a
multi-center clinical trial: IMPRESS (NCT00425932). Arthritis
Res Ther 2013 Mar 20;15(2):R44.
20. Roemer FW, Kwoh CK, Hannon MJ, Crema MD, Moore CE,
Jakicic JM, et al. Semiquantitative assessment of focal cartilage
damage at 3T MRI: a comparative study of dual echo at steady
state (DESS) and intermediate-weighted (IW) fat suppressed
fast spin echo sequences. Eur J Radiol 2011 Nov;80(2):
e126e31.
21. Del Grande F, Santini F, Herzka DA, Aro MR, Dean CW, Gold GE,
et al. Fat-suppression techniques for 3-T MR imaging of the
musculoskeletal system. Radiographics 2014 JaneFeb;34(1):
217e33.
22. Strickland CD, Kijowski R. Morphologic imaging of articular
cartilage. Magnetic Reson Imaging Clin N Am 2011 May;19(2):
229e48.
23. Crema MD, Roemer FW, Marra MD, Burstein D, Gold GE,
Eckstein F, et al. Articular cartilage in the knee: current MR
imaging techniques and applications in clinical practice and
research. Radiographics 2011 JaneFeb;31(1):37e61.
24. Thomsen HS. Nephrogenic systemic ﬁbrosis: history and
epidemiology. Radiol Clin N Am 2009 Sep;47(5):827e31. vi.
25. Miese F, Buchbender C, Scherer A, Wittsack HJ, Specker C,
Schneider M, et al. Molecular imaging of cartilage damage of
ﬁnger joints in early rheumatoid arthritis with delayed
gadolinium-enhanced magnetic resonance imaging. Arthritis
Rheum 2012 Feb;64(2):394e9.
26. Williams A, Shetty SK, Burstein D, Day CS, McKenzie C. Delayed
gadolinium enhanced MRI of cartilage (dGEMRIC) of the ﬁrst
carpometacarpal (1CMC) joint: a feasibility study. Osteoar-
thritis Cartilage 2008 Apr;16(4):530e2.27. Felson DT, Nevitt MC. Blinding images to sequence in osteo-
arthritis: evidence from other diseases. Osteoarthritis Cartilage
2009 Mar;17(3):281e3.
28. Guermazi A, Hunter DJ, Li L, Benichou O, Eckstein F, Kwoh CK,
et al. Different thresholds for detecting osteophytes and joint
space narrowing exist between the site investigators and the
centralized reader in a multicenter knee osteoarthritis study-
edata from the Osteoarthritis Initiative. Skelet Radiol 2012
Feb;41(2):179e86 [Comparative Study Multicenter Study
Research Support, N.I.H., Extramural Research Support, Non-
U.S. Gov't].
29. Maheu E, Cadet C, Gueneugues S, Ravaud P, Dougados M.
Reproducibility and sensitivity to change of four scoring
methods for the radiological assessment of osteoarthritis of
the hand. Ann Rheum Dis 2007 Apr;66(4):464e9.
30. Bijsterbosch J, Haugen IK, Malines C, Maheu E, Rosendaal FR,
Watt I, et al. Reliability, sensitivity to change and feasibility of
three radiographic scoring methods for hand osteoarthritis.
Ann Rheum Dis 2011 Aug;70(8):1465e7 [Comparative Study
Multicenter Study Research Support, Non-U.S. Gov't].
31. Botha-Scheepers S, Watt I, Breedveld FC, Kloppenburg M.
Reading radiographs in pairs or in chronological order in-
ﬂuences radiological progression in osteoarthritis. Rheuma-
tology (Oxford) 2005 Nov;44(11):1452e5 [Comparative
Study].
32. Kellgren JH, Lawrence JS. Radiological assessment of osteo-
arthrosis. Ann Rheum Dis 1957 Dec;16(4):494e502.
33. Marshall M, Dziedzic KS, van der Windt DA, Hay EM.
A systematic search and narrative review of radiographic
deﬁnitions of hand osteoarthritis in population-based studies.
Osteoarthritis Cartilage 2008 Feb 1;16(2):219e26.
34. Kellgren J, Jeffrey MR, Ball J. The Epidemiology of Chronic
Rheumatism Volume II Atlas of Standard Radiographs of
Arthritis. Oxford: Blackwell Scientiﬁc Publications; 1963 Feb
14.
35. Spector TD, Cooper C. Radiographic assessment of osteoar-
thritis in population studies: whither Kellgren and Lawrence?
Osteoarthritis Cartilage 1993 Oct 1;1(4):203e6.
36. Kallman DA, Wigley FM, Scott WW, Hochberg MC, Tobin JD.
New radiographic grading scales for osteoarthritis of the hand.
Reliability for determining prevalence and progression.
Arthritis Rheum 1989 Dec 1;32(12):1584e91.
37. Altman RD, Hochberg M, Murphy Jr WA, Wolfe F, Lequesne M.
Atlas of individual radiographic features in osteoarthritis.
Osteoarthritis Cartilage 1995 Sep;(3 Suppl A):3e70 [Research
Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-
P.H.S. Research Support, U.S. Gov't, P.H.S.].
38. Altman RD, Gold GE. Atlas of individual radiographic features
in osteoarthritis, revised. Osteoarthritis Cartilage 2007;(15
Suppl A):A1eA56 [Research Support, Non-U.S. Gov't].
39. Lane NE, Nevitt MC, Genant HK, Hochberg MC. Reliability of
new indices of radiographic osteoarthritis of the hand and hip
and lumbar disc degeneration. J Rheumatol 1993 Nov
1;20(11):1911e8.
40. Kessler S, Dieppe P, Fuchs J, Stürmer T, Günther KP. Assessing
the prevalence of hand osteoarthritis in epidemiological
studies. The reliability of a radiological hand scale. Ann Rheum
Dis 2000 Apr 1;59(4):289e92.
41. Verbruggen G, Veys EM. Numerical scoring systems for the
progression of osteoarthritis of the ﬁnger joints. Rev Rhum
Engl Ed 1995 Jun 1;62(6 Suppl 1):27Se32S.
42. Verbruggen G, Veys EM. Numerical scoring systems for the
anatomic evolution of osteoarthritis of the ﬁnger joints.
Arthritis Rheum 1996 Feb;39(2):308e20.
D.J. Hunter et al. / Osteoarthritis and Cartilage 23 (2015) 732e74674643. Verbruggen G, Wittoek R, Cruyssen BV, Elewaut D. Morbid
anatomy of 'erosive osteoarthritis' of the interphalangeal
ﬁnger joints: an optimised scoring system to monitor disease
progression in affected joints. Ann Rheum Dis 2010
May;69(5):862e7.
44. Dacre JE, Coppock JS, Herbert KE, Perrett D, Huskisson EC.
Development of a new radiographic scoring system using
digital image analysis. Ann Rheum Dis 1989 Mar 1;48(3):
194e200.
45. Angwin J, Lloyd A, Heald G, Nepom G, Binks M, James MF.
Radiographic hand joint space width assessed by computer is a
sensitive measure of change in early rheumatoid arthritis.
J Rheumatol 2004 Jun 1;31(6):1050e61.
46. Sharp JT, Gardner JC, Bennett EM. Computer-based methods
for measuring joint space and estimating erosion volume in
the ﬁnger and wrist joints of patients with rheumatoid
arthritis. Arthritis Rheum 2000 Jun 1;43(6):1378e86.
47. Sharp JT, van der Heijde D, Angwin J, Duryea J, Moens HJ,
Jacobs JW, et al. Measurement of joint space width and erosion
size. J Rheumatol [Review] 2005 Dec;32(12):2456e61.
48. van 't Klooster R, Hendriks EA, Watt I, Kloppenburg M,
Reiber JHC, Stoel BC. Automatic quantiﬁcation of osteoarthritis
in hand radiographs: validation of a new method to measure
joint space width. Osteoarthritis Cartilage 2008 Jan 1;16(1):
18e25.
49. Kwok WY, Bijsterbosch J, Malm SH, Biermasz NR, Huetink K,
Nelissen RG, et al. Validity of joint space width measurements
in hand osteoarthritis. Osteoarthritis Cartilage 2011 Sep 5.
50. Haugen IK, Boyesen P, Slatkowsky-Christensen B, Sesseng S,
Bijsterbosch J, van der Heijde D, et al. Comparison of features
by MRI and radiographs of the interphalangeal ﬁnger joints in
patients with hand osteoarthritis. Ann Rheum Dis 2012
Mar;71(3):345e50 [Comparative Study Evaluation Studies
Research Support, Non-U.S. Gov't].
51. Kwok WY, Kortekaas MC, Reijnierse M, van der Heijde D,
Bloem JL, Kloppenburg M. MRI in hand osteoarthritis: valida-
tion of the Oslo hand osteoarthritis MRI-scoring method and
association with pain. Osteoarthritis Cartilage 2011 Sep 29:
1e31 (abstract).
52. Keen HI, Lavie F, Wakeﬁeld RJ, D'Agostino MA, Hammer HB,
Hensor E, et al. The development of a preliminary ultrasono-
graphic scoring system for features of hand osteoarthritis. Ann
Rheum Dis 2008 May;67(5):651e5 [Evaluation Studies
Research Support, Non-U.S. Gov't Review].
53. Mathiessen A, Haugen IK, Slatkowsky-Christensen B,
Bøyesen P, Kvien TK, Hammer HB. Ultrasonographic assess-
ment of osteophytes in 127 patients with hand osteoarthritis:
exploring reliability and associations with MRI, radiographs
and clinical joint ﬁndings. Ann Rheum Dis 2013 Jan;72(1):
51e6.
54. Hammer HB, Bolton-King P, Bakkeheim V, Berg TH, Sundt E,
Kongtorp AK, et al. Examination of intra and interrater reli-
ability with a new ultrasonographic reference atlas for scoring
of synovitis in patients with rheumatoid arthritis. Ann Rheum
Dis 2011 Nov 1;70(11):1995e8.
55. Iagnocco A, Conaghan PG, Aegerter P, Moller I, Bruyn GA,
Chary-Valckenaere I, et al. The reliability of musculoskeletalultrasound in the detection of cartilage abnormalities at the
metacarpo-phalangeal joints. Osteoarthritis Cartilage 2012
Oct;20(10):1142e6.
56. Kortekaas MC, Kwok WY, Reijnierse M, Watt I, Huizinga TW,
Kloppenburg M. Pain in hand osteoarthritis is associated with
inﬂammation: the value of ultrasound. Ann Rheum Dis 2010
Jul;69(7):1367e9.
57. Kortekaas MC, Kwok WY, Reijnierse M, Huizinga TW,
Kloppenburg M. Osteophytes and joint space narrowing are
independently associated with pain in ﬁnger joints in hand
osteoarthritis. Ann Rheum Dis 2011 Oct;70(10):1835e7.
58. Vlychou M, Koutroumpas A, Malizos K, Sakkas LI. Ultrasono-
graphic evidence of inﬂammation is frequent in hands of pa-
tients with erosive osteoarthritis. Osteoarthritis Cartilage 2009
Oct;17(10):1283e7.
59. Wittoek R, Carron P, Verbruggen G. Structural and inﬂamma-
tory sonographic ﬁndings in erosive and non-erosive osteo-
arthritis of the interphalangeal ﬁnger joints. Ann Rheum Dis
2010 Dec;69(12):2173e6.
60. Wittoek R, Jans L, Lambrecht V, Carron P, Verstraete K,
Verbruggen G. Reliability and construct validity of ultraso-
nography of soft tissue and destructive changes in erosive
osteoarthritis of the interphalangeal ﬁnger joints: a compari-
son with MRI. Ann Rheum Dis 2011 Feb;70(2):278e83.
61. Kortekaas MC, Kwok WY, Reijnierse M, Huizinga TW,
Kloppenburg M. In erosive hand osteoarthritis more inﬂam-
matory signs on ultrasound are found than in the rest of hand
osteoarthritis. Ann Rheum Dis 2013 Jun;72(6):930e4.
62. Keen HI, Wakeﬁeld RJ, Grainger AJ, Hensor EM, Emery P,
Conaghan PG. Can ultrasonography improve on radiographic
assessment in osteoarthritis of the hands? A comparison be-
tween radiographic and ultrasonographic detected pathology.
Ann Rheum Dis 2008 Aug;67(8):1116e20 [Comparative
Study].
63. Keen HI, Wakeﬁeld RJ, Grainger AJ, Hensor EM, Emery P,
Conaghan PG. An ultrasonographic study of osteoarthritis of
the hand: synovitis and its relationship to structural pathology
and symptoms. Arthritis Rheum 2008 Dec 15;59(12):1756e63.
64. Conaghan PG, D'Agostino MA, Le Bars M, Baron G,
Schmidely N, Wakeﬁeld R, et al. Clinical and ultrasonographic
predictors of joint replacement for knee osteoarthritis: results
from a large, 3-year, prospective EULAR study. Ann Rheum Dis
2010 Apr;69(4):644e7 [Multicenter Study Research Support,
Non-U.S. Gov't].
65. Keen HI, Mease PJ, Bingham 3rd CO, Giles JT, Kaeley G,
Conaghan PG. Systematic review of MRI, ultrasound, and
scintigraphy as outcome measures for structural pathology in
interventional therapeutic studies of knee arthritis: focus on
responsiveness. J Rheumatol [Review] 2011 Jan;38(1):142e54.
66. D'Agostino MA, Conaghan P, Le Bars M, Baron G, Grassi W,
Martin-Mola E, et al. EULAR report on the use of ultrasonog-
raphy in painful knee osteoarthritis. Part 1: prevalence of
inﬂammation in osteoarthritis. Ann Rheum Dis 2005
Dec;64(12):1703e9 [Multicenter Study Research Support,
Non-U.S. Gov't].
